Stay Alert for a New Colchicine Product NOT Approved for Gout

December 2023

You’ll hear about a new Rx colchicine product called Lodoco.

It’s NOT approved for gout...like the colchicine 0.6 mg products we’re used to dispensing.

Instead, think of Lodoco as low-dose colchicine. It’s a 0.5 mg tablet...approved to reduce cardiovascular risk in patients with coronary heart disease.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Take Precautions With Flammable Meds
Transplantation Keep Immunosuppressant Meds for Transplant Patients Straight
Inventory Management Take Stock of Best Practices for Expiring or Excess Inventory
Iron Know How IV Iron Products Compare
Naloxone Think of Nalmefene as Another Option to Reverse Opioid Overdose
Hypertension Prevent Common Issues With First-Line Blood Pressure Meds
Cardiology Stay Alert for a New Colchicine Product NOT Approved for Gout
NatMed Spotlight Be on the Lookout for Interactions With St. John’s Wort

Stay Alert for a New Colchicine Product NOT Approved for Gout

Practical advice for a better career, with unlimited access to CE

Table of Contents